335 related articles for article (PubMed ID: 34996416)
1. A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.
Fan D; Yang Y; Zhang W
BMC Pulm Med; 2022 Jan; 22(1):27. PubMed ID: 34996416
[TBL] [Abstract][Full Text] [Related]
2. Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.
Sheng J; Liu L; Dong T; Wu X
J Chemother; 2022 Oct; 34(6):401-413. PubMed ID: 34861803
[TBL] [Abstract][Full Text] [Related]
3. Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.
Niu R; Li D; Chen J; Zhao W
Cell Cycle; 2022 Jan; 21(1):86-100. PubMed ID: 34919024
[TBL] [Abstract][Full Text] [Related]
4. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
5. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
6. Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.
Wang L; Li M; Lian R
Histol Histopathol; 2022 Jul; 37(7):637-654. PubMed ID: 35133000
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
Chang F; Li J; Sun Q; Wei S; Song Y
Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
[TBL] [Abstract][Full Text] [Related]
8. Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1.
Ouyang K; Xie D; Liao H; He Y; Xiong H
J Cardiothorac Surg; 2024 Apr; 19(1):178. PubMed ID: 38581057
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of circ_PLXND1 inhibits tumorigenesis of non-small cell lung carcinoma via miR-1287-5p/ERBB3 axis.
Wu J; Liu C; Yu G
Thorac Cancer; 2023 Jun; 14(17):1543-1555. PubMed ID: 37073425
[TBL] [Abstract][Full Text] [Related]
10. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network.
Qu R; Ma J
Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737
[TBL] [Abstract][Full Text] [Related]
11. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
Liu Y; Li C; Liu H; Wang J
Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
[TBL] [Abstract][Full Text] [Related]
12. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
Sun C; Gao W; Liu J; Cheng H; Hao J
Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
[TBL] [Abstract][Full Text] [Related]
13. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
Gong J; He L; Ma J; Zhang J; Wang L; Wang J
J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
[TBL] [Abstract][Full Text] [Related]
14. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
[TBL] [Abstract][Full Text] [Related]
15. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
16. MiR-142-5p reverses the resistance to gefitinib through targeting HOXD8 in lung cancer cells.
Zhu W; Wang JP; Meng QZ; Zhu F; Hao XF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4306-4313. PubMed ID: 32373967
[TBL] [Abstract][Full Text] [Related]
17. Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis.
Yu X; Fu X; Zhang X; Bai C; Wang Y
Anticancer Drugs; 2022 Feb; 33(2):158-166. PubMed ID: 34694278
[TBL] [Abstract][Full Text] [Related]
18. MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.
Li Q; Wang Y; He J
J Clin Lab Anal; 2021 Jul; 35(7):e23853. PubMed ID: 34057242
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis.
Yu B; Zheng L; Tang H; Wang W; Lin Y
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]